Prosecutors seeking 15 years behind bars for Theranos CEO Elizabeth Holmes
Federal prosecutors are recommending a sentence of 15 years in prison for disgraced Theranos founder Elizabeth Holmes, Reuters reported Friday.
Holmes, 38, was found guilty this past January of defrauding investors about the merits of Theranos' blood-testing machines. She is facing a maximum of 20 years in prison, though experts predicted her actual sentence would likely be shorter.
In addition to the recommended sentence, U.S. attorneys said Holmes should be forced to pay $800 million in restitution to investors, per Reuters.
The Week
Escape your echo chamber. Get the facts behind the news, plus analysis from multiple perspectives.
Sign up for The Week's Free Newsletters
From our morning news briefing to a weekly Good News Newsletter, get the best of The Week delivered directly to your inbox.
From our morning news briefing to a weekly Good News Newsletter, get the best of The Week delivered directly to your inbox.
Holmes is scheduled to be sentenced next week, and her time in prison will be the final domino to fall in one of the largest investment fraud schemes in American history, as well as one of the most notable falls from grace in tech history. Forbes had at one point named Holmes the youngest self-made female billionaire in the country, and Theranos had an estimated valuation of $9 billion.
However, an investigation by The Wall Street Journal soon revealed that Holmes and other top officials at Theranos had lied to investors about the accuracy and capabilities of their blood-testing machines. As the investigation grew to involve the federal government, Theranos' value soon plunged to zero, and the SEC soon charged Holmes with "massive fraud" related to her running of the company.
According to reports from The Associated Press and Bloomberg, Holmes is seeking an 18-month house arrest sentence in lieu of prison time. However, it was noted that, given the scope of her crimes, this request was unlikely to be granted.
A free daily email with the biggest news stories of the day – and the best features from TheWeek.com
Justin Klawans has worked as a staff writer at The Week since 2022. He began his career covering local news before joining Newsweek as a breaking news reporter, where he wrote about politics, national and global affairs, business, crime, sports, film, television and other news. Justin has also freelanced for outlets including Collider and United Press International.
-
How are these Epstein files so damaging to Trump?TODAY'S BIG QUESTION As Republicans and Democrats release dueling tranches of Epstein-related documents, the White House finds itself caught in a mess partially of its own making
-
Margaret Atwood’s memoir, intergenerational trauma and the fight to make spousal rape a crime: Welcome to November booksThe Week Recommends This month's new releases include ‘Book of Lives: A Memoir of Sorts’ by Margaret Atwood, ‘Cursed Daughters’ by Oyinkan Braithwaite and 'Without Consent' by Sarah Weinman
-
‘Tariffs are making daily life less affordable now’Instant Opinion Opinion, comment and editorials of the day
-
More adults are dying before the age of 65Under the radar The phenomenon is more pronounced in Black and low-income populations
-
Ultra-processed AmericaFeature Highly processed foods make up most of our diet. Is that so bad?
-
Peanut allergies have plummeted in childrenUnder the radar Early introduction could be an effective prevention method
-
Climate change is getting under our skinUnder the radar Skin conditions are worsening because of warming temperatures
-
Is this the end of ultraprocessed foods?Today's Big Question California law and the MAHA movement are on the same track
-
Bluetoothing: the phenomenon driving HIV spike in FijiUnder the Radar ‘Blood-swapping’ between drug users fuelling growing health crisis on Pacific island
-
FDA OKs generic abortion pill, riling the rightSpeed Read The drug in question is a generic version of mifepristone, used to carry out two-thirds of US abortions
-
The new Stratus Covid strain – and why it’s on the riseThe Explainer ‘No evidence’ new variant is more dangerous or that vaccines won’t work against it, say UK health experts
